Effect of Low-Density Lipoprotein Apheresis on Lipoprotein-Associated Phospholipase A2

This publication has 11 references indexed in Scilit:

• Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins—reduction of circulating proinflammatory and procoagulatory markers
  Atherosclerosis, 2004
• Lipoprotein-Associated Phospholipase A ₂ , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
  Circulation, 2004
• C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis
  Atherosclerosis, 2001
• Lipoprotein-Associated Phospholipase A₂as an Independent Predictor of Coronary Heart Disease
  New England Journal of Medicine, 2000
• Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia.
  Current Atherosclerosis Reports, 2000
• Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease
  Atherosclerosis, 2000
• Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
  Circulation, 1997
• H.E.L.P. Apheresis Therapy in the Treatment of Severe Hypercholesterolemia: 10 Years of Clinical Experience
  Artificial Organs, 1996
• Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP)
  Journal of Clinical Apheresis, 1996
• Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein.
  The Journal of Experimental Medicine, 1982